Keyword summary
79%34 analyzed articles/videos10,133 analyzed words
BS Summary: These Pharmaceuticals results contain 51 faulty reasoning types, including Optimism Bias, Biased Writer Voice, and Negativity Bias, with Framing Effect as the most egregious example at 12.9% saturation with 5,253 hits. Analysis detected 39,042 faulty-reasoning hits from 40,741 analyzed words across 34 articles, generating a BS Score of 1.9% and a BS Rank of 20% (30,022 of 37,536 keywords). This Pharmaceuticals is better (less manipulative) than 80.00% of the peer group.

Ranking context

Position among analyzed keywords

20% percentile
025507510020.0% percentile
1.9% BS Score34 analyzed articles40.7K analyzed words

Reasoning profile

Selected profile versus the sitewide rate

KeywordSitewideShared scale 0–50%
0.0%10%20%30%40%50%Framing EffectSitewide 26.9%Keyword 12.9%12.9%Negativity BiasSitewide 19.2%Keyword 6.7%6.7%Appeal to EmotionSitewide 15.9%Keyword 4.3%4.3%Appeal to AuthoritySitewide 11.1%Keyword 3.6%3.6%Availability HeuristicSitewide 9.1%Keyword 3.0%3.0%In-Group BiasSitewide 6.9%Keyword 0.8%0.8%Attempt to Sell a Product…Sitewide 0.5%Keyword 6.3%6.3%Halo EffectSitewide 6.7%Keyword 1.8%1.8%Optimism BiasSitewide 6.0%Keyword 10.3%10.3%AnecdotalSitewide 5.2%Keyword 1.4%1.4%

Sitewide departure map

Above the diagonal means this profile uses the pattern more often

0.0%0.0%10%10%20%20%30%30%40%40%50%50%Framing Effect: Keyword 12.9%, sitewide 26.9%Negativity Bias: Keyword 6.7%, sitewide 19.2%Appeal to Emotion: Keyword 4.3%, sitewide 15.9%Appeal to Authority: Keyword 3.6%, sitewide 11.1%Optimism Bias: Keyword 10.3%, sitewide 6.0%Availability Heuristic: Keyword 3.0%, sitewide 9.1%Hasty Generalization: Keyword 4.9%, sitewide 8.1%Confirmation Bias: Keyword 4.8%, sitewide 7.5%Biased Writer Voice: Keyword 7.2%, sitewide 5.3%In-Group Bias: Keyword 0.8%, sitewide 6.9%Halo Effect: Keyword 1.8%, sitewide 6.7%Attempt to Sell a Product or Service: Keyword 6.3%, sitewide 0.5%Anecdotal: Keyword 1.4%, sitewide 5.2%Overconfidence Bias: Keyword 2.1%, sitewide 4.6%Anchoring Bias: Keyword 2.3%, sitewide 4.0%Self-Serving Bias: Keyword 1.0%, sitewide 3.7%Post Hoc (False Cause): Keyword 2.0%, sitewide 3.3%Out-Group Homogeneity Bias: Keyword 0.1%, sitewide 3.1%Fundamental Attribution Error: Keyword 0.5%, sitewide 2.7%Recency Bias: Keyword 1.3%, sitewide 2.7%Loss Aversion: Keyword 1.2%, sitewide 2.5%Ambiguity (Equivocation): Keyword 2.3%, sitewide 0.8%Bandwagon: Keyword 0.4%, sitewide 2.2%Status Quo Bias: Keyword 1.0%, sitewide 2.2%Framing EffectSitewide rateKeyword rate

Analyzed articles and videos

The Trump administration’s best healthcare idea isn’t the one getting attention68%
American Thinker94%By David Hogberg89%7/25/2026, 12:00:00 AM
Merck strikes voluntary licensing deals in poor countries for an experimental HIV prevention pill81%
STAT44%By Ed Silverman62%7/24/2026, 10:45:00 AM
America Still Has the Upper Hand Over China71%
Foreign Affairs46%By Ben A. Vagle92% Stephen G. Brooks92%7/24/2026, 4:00:00 AM
In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides77%
STAT44%By Sarah Todd0% Lizzy Lawrence80%7/23/2026, 8:08:56 PM
FDA is urged by advocacy group to ban DTC prescription drug ads59%
STAT44%By Ed Silverman62%7/23/2026, 1:00:00 PM
The next step of site-neutral, and a fiery PBM hearing54%
STAT44%By Bob Herman70%7/20/2026, 2:38:04 PM
Eli Lilly makes $3.8 billion bet on psychedelic drugs100%
Semafor84%By Tom Chivers87%7/17/2026, 12:54:10 PM
Predicting biotech clinical trials and a new Alzheimer’s drug controversy74%
STAT44%By Elaine Chen14% Adam Feuerstein43% Allison DeAngelis25%7/16/2026, 8:06:43 PM
Eli Lilly to acquire psychedelics-focused biotech AtaiBeckley41%
STAT44%By Adam Feuerstein43%7/16/2026, 11:28:27 AM
At key hearing, Kennedy’s ouster of former CDC director looms over nominee to replace her75%
STAT44%By Chelsea Cirruzzo80%7/15/2026, 8:26:04 PM